Identification of mechanisms driving acquired chemoresistance in preclinical breast cancer models of taxane resistance

被引：0
|
作者：
Taylor, Karen J. [1 ]
Lyttle, Nicola [2 ]
Lao, Linda [2 ]
Gourley, Charlie [1 ]
Cameron, David A. [1 ]
Bartlett, John M. S. [2 ]
Spears, Melanie [2 ]
机构：
[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[2] Ontario Inst Canc Res, Toronto, ON, Canada
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P6-03-21
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-03-21
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Acquired resistance to everolimus occurs independently of mTORC1 inhibition in preclinical in vivo models of ER plus breast cancer
    O'Brien, Neil A.
    Conklin, Dylan
    Ching, Michaela
    Tong, Luo
    Ayala, Raul
    Issakhanian, Shawnt
    Hurvitz, Sara A.
    di Tomaso, Emmanuelle
    Linnartz, Ronald
    Finn, Richard S.
    Hirawat, Samit
    Slamon, Dennis J.
    CANCER RESEARCH, 2015, 75
  • [22] Identification of novel epigenetic modulators of acquired chemoresistance in colon cancer
    Enreig, E.
    Mancino, M.
    Fernandez, P.
    Casado, F. J.
    Gascon, P.
    Carbo, N.
    Ametller, E.
    Almendro, V.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S111 - S111
  • [23] Long Noncoding RNAs in Taxane Resistance of Breast Cancer
    Chen, Hailong
    Zhang, Mengwen
    Deng, Yongchuan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [24] The role of autophagy in taxane resistant breast cancer models
    Rechache, Nesrin S.
    Riggins, Rebecca B.
    Shajahan, Ayesha N.
    Zwart, Alan
    Clarke, Robert
    CANCER RESEARCH, 2010, 70
  • [25] Molecular mechanisms of breast cancer chemoresistance by immune checkpoints
    Dastmalchi, Narges
    Safaralizadeh, Reza
    Baghbanzadeh, Amir
    Hajiasgharzadeh, Khalil
    Asl, Elmira Roshani
    Amini, Mohammad
    Baradaran, Behzad
    LIFE SCIENCES, 2020, 263
  • [26] Acquired tamoxifen resistance in human breast cancer - potential mechanisms and clinical implications
    Johnston, SRD
    ANTI-CANCER DRUGS, 1997, 8 (10) : 911 - 930
  • [27] Acquired 5-Fluorouracil Resistance in Human Pancreatic Carcinoma Cells - A Paradigm for Chemoresistance Mechanisms In Pancreatic Cancer
    Schober, Marvin
    Jesenofsky, Ralf
    Faissner, Ralf
    Krug, Sebastian
    Weidenauer, Cornelius
    Hagmann, Wolfgang
    Haas, Stephan L.
    Heuchel, Rainer L.
    Loehr, Matthias J.
    JOURNAL OF THE PANCREAS, 2015, 16 (03): : 256 - 265
  • [28] Mechanisms of acquired resistance to AKT inhibitor capivasertib in AKT1 mutant patient derived breast cancer models
    Mearns, Sarah
    Pearson, Alex
    Sim, Li-Xuan
    Cutts, Rosalind
    Sritharan, Prithika
    Shah, Heena
    Gulati, Aditi
    Williamson, Stuart
    Barry, Simon
    De-Bruin, Elza
    Turner, Nicholas C.
    CANCER RESEARCH, 2024, 84 (07)
  • [29] Development of preclinical models to accelerate the identification of next generation treatments for patients with acquired resistance to targeted therapies
    Deas, Olivier
    Bigot, Ludovic
    Lang, Guillaume
    Loriot, Yohann
    Andre, Fabrice
    Soria, Jean Charles
    Besse, Benjamin
    Cairo, Stefano
    Tavernier, Marie
    Mevel, Katell
    Le Ven, Enora
    Judde, Jean-Gabriel
    Friboulet, Luc
    CANCER RESEARCH, 2018, 78 (13)
  • [30] Roles of multidrug resistance genes in breast cancer chemoresistance
    Kuo, M. Tien
    BREAST CANCER CHEMOSENSITIVITY, 2007, 608 : 23 - 30
12345